Results 241 to 250 of about 1,136,503 (270)
Some of the next articles are maybe not open access.
Effects of anti-IL-23 and anti-IL-17: The hidden side of spondyloarthritis polymorphism?
Joint Bone Spine, 2020Daniel Wendling +3 more
openaire +2 more sources
Resistance Mechanisms to Anti-PD Cancer Immunotherapy
Annual Review of Immunology, 2022Matthew Vesely, Lieping Chen
exaly
Fluorescent cellulose-based materials for information encryption and anti-counterfeiting
Coordination Chemistry Reviews, 2023Yongqian Xu, Sg Sun, Hongjuan Li
exaly
Luminescence anti‐counterfeiting: From elementary to advanced
Aggregate, 2021Hongyue Zhang, Jihong Yu
exaly
Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity
Cell, 2020Brian C Miller +2 more
exaly
Psoriatic arthritis and obesity: the role of anti-IL-12/IL-23 treatment
Clinical Rheumatology, 2019L. Costa +9 more
semanticscholar +1 more source
Gastroenterology & hepatology
The interleukin (IL)-12/IL-23 pathway is one of many proposed mechanistic pathways of intestinal inflammation. Earlier studies introduced IL-12 as a major cytokine in the pathogenesis of inflammatory bowel disease. However, the discovery of IL-23 drew attention toward this new cytokine.
Amir, Kashani, David A, Schwartz
openaire +1 more source
The interleukin (IL)-12/IL-23 pathway is one of many proposed mechanistic pathways of intestinal inflammation. Earlier studies introduced IL-12 as a major cytokine in the pathogenesis of inflammatory bowel disease. However, the discovery of IL-23 drew attention toward this new cytokine.
Amir, Kashani, David A, Schwartz
openaire +1 more source

